Asia Pacific Virology Market By Type (Diagnosing Test, Viral Infection Controlling Methods, Antiviral Chemotherapy, Interferons) By Application (Skin And Soft Tissue Infections, GI Tract Infections, Urinary Tract Infection, Eye Infections, Respiratory Tract Infections, Sexually Transmitted, Perinatal Infections. STDs, Urinary Tract Infections, And Respiratory Tract Infections) By End User (Hospitals, Clinics, Laboratories, Diagnostic Centers, Blood Banks, Pharmacies) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)

Asia Pacific Virology Market By Type (Diagnosing Test, Viral Infection Controlling Methods, Antiviral Chemotherapy, Interferons) By Application (Skin And Soft Tissue Infections, GI Tract Infections, Urinary Tract Infection, Eye Infections, Respiratory Tract Infections, Sexually Transmitted, Perinatal Infections. STDs, Urinary Tract Infections, And Respiratory Tract Infections) By End User (Hospitals, Clinics, Laboratories, Diagnostic Centers, Blood Banks, Pharmacies) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)

ID: 5114 | Pages: 145 | December 2017 | Region: Asia Pacific


Asia Pacific Virology Market Size is worth USD xx million in 2016 and estimated to grow at a CAGR of xx.xx%, to reach USD xx million by 2021. The Asia Pacific Virology market is developing at an exceptionally quick pace.

Virology refers to the study of viruses which are submicroscopic, parasitic particles of genetic material contained in a protein coat and virus-like agents. It mainly focuses on their structure, classification and evolution, their ways to infect and exploit host cells for reproduction, their interaction with host organism physiology and immunity, the they cause, the techniques to isolate and culture them, and their use in research and therapy. Virology is generally considered as subfield of microbiology.

The significant drivers are various treatments and diagnostic processes that use virology application. Increasing applications of virology in gene therapy, phage therapy, formulation of vaccines etc. is also expected to boost the market. Increasing Public awareness programmes conducted worldwide on flu, zika virus, STDs, AIDS, and Ebola virus are also a key factor driving the market. However quality and safety standards is a longstanding challenge, and stringent approval processes for antiviral drugs may limit the growth of this industry.

The Asia Pacific Virology market is segmented on the basis of Type, application, end user and region. Based on Type the market is segmented into Diagnosing Test, Viral Infection Controlling Methods, Antiviral Chemotherapy, Interferons. Based on Application the market is segmented into Skin and Soft Tissue Infections, GI Tract Infections, Urinary Tract infection, Eye Infections, Respiratory Tract Infections, Sexually Transmitted , Perinatal Infections. STDs, Urinary tract infections, and respiratory tract infections. Based on end user the market is segmented into hospitals, Clinics, Laboratories, Diagnostic Centers, Blood Banks, and Pharmacies. Hospitals and Clinics are largest segment which account for nearly 50% of the market share.

Asia Pacific is geographically segmented into China, India, Japan, South Korea, Taiwan, Australia and South East Asia. Asia Pacific region is expected to witness significant growth. China is expected to dominate the market followed by India.

Boehringer Ingelheim Corporation, Merck and Co. Inc, GlaxoSmithKline plc, Abbott Laboratories, Novartis International AG, Siemens, Johnson & Johnson, AstraZeneca AB, and Roche. are the some of the key players in the Asia Pacific Virology market.

1. Introduction                                                                 

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 Epidemology                                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Type                                                              

                                5.1.1 Introduction                                           

                                5.1.2 Diagnosing Test                                     

                                                5.1.2.1 DNA Viruses                       

                                                5.1.2.2 RNA Viruses                        

                                                5.1.2.3 Prions Diagnostic Test                     

                                                5.1.2.4 Other Viral Tests                               

                                5.1.3 Viral Infection Controlling Methods                                             

                                                5.1.3.1 Immunoprophylaxis                        

                                                5.1.3.2 Active Prophylaxis (Vaccines)                      

                                                5.1.3.3 Passive Prophylaxis                         

                                5.1.4 Antiviral Chemotherapy                                    

                                                5.1.4.1 Virucidal Agents                

                                                5.1.4.2 Antiviral Agents                 

                                                5.1.4.3 Immunomodulators                        

                                5.1.5 Interferons                                             

                                                5.1.5.1 Cytokines                             

                                5.1.6 Y-o-Y Growth Analysis, By Type                                     

                                5.1.7 Market Attractiveness Analysis, By Type                                   

                                5.1.8 Market Share Analysis, By Type                                     

                5.2 Application                                                 

                                5.2.1 Introduction                                           

                                5.2.2 Skin and Soft Tissue Infections                                       

                                5.2.3 Respiratory Tract Infections                                             

                                5.2.4 GI Tract Infections                               

                                5.2.5 Urinary Tract Infections                                     

                                5.2.6  Eye Infections                                       

                                5.2.7 CNS Infections                                       

                                5.2.8 Sexually Transmitted Diseases                                       

                                5.2.9 Perinatal Infections                                             

                                5.2.10 Y-o-Y Growth Analysis, By Application                                      

                                5.2.11  Market Attractiveness Analysis, By Application                                   

                                5.2.12  Market Share Analysis, By Application                                     

                5.3 End User                                                      

                                5.3.1 Introduction                                           

                                5.3.2 Hospitals                                  

                                5.3.3 Clinics                                        

                                5.3.4 Laboratories                                           

                                5.3.5 Diagnostic Centres                                               

                                5.3.6 Blood Banks                                            

                                5.3.7 Pharmacies                                             

                                5.3.8 Y-o-Y Growth Analysis, By End User                                             

                                5.3.9  Market Attractiveness Analysis, By End User                                          

                                5.3.10  Market Share Analysis, By End User                                         

6. Geographical Analysis                                                                              

                6.1 Introduction                                                               

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

                                                6.1.3.1 By Geographical Area                     

                                                6.1.3.2 By Type                 

                                                6.1.3.3 By Application                    

                                                6.1.3.4 By End User                        

                                6.1.4  Market Attractiveness Analysis                                     

                                                6.1.4.1 By Geographical Area                     

                                                6.1.4.2 By Type                 

                                                6.1.4.3 By Application                    

                                                6.1.4.4 By End User                        

                                6.1.5  Market Share Analysis                                      

                                                6.1.5.1 By Geographical Area                     

                                                6.1.5.2 By Type                 

                                                6.1.5.3 By Application                    

                                                6.1.5.4 By End User                        

                6.2 China                                                             

                6.3 India                                                              

                6.4 Japan                                                            

                6.5 South Korea                                                               

                6.6 Australia                                                      

7. Strategic Analysis                                                                       

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8. Market Leaders' Analysis                                                                        

                8.1 Johnson & Johnson                                                 

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Abbott Laboratories                                               

                8.3 GlaxoSmithKline plc                                                

                8.4 Boehringer Ingelheim Corporation                                                   

                8.5 Merck and Co. Inc.                                                  

                8.6 Novartis International AG                                                    

                8.7 Siemens                                                       

                8.8 AstraZeneca AB                                                        

                8.9 Roche                                                           

                8.10 Abivax                                                        

9. Competitive Landscape                                                                           

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10. Market Outlook and Investment Opportunities                                                                         

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures                                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Type, application, end user and region along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia Pacific Virology Market By Type, From 2016-2021 ( USD Million )
  2. Asia Pacific Diagnosing Test Market By Region, From 2016-2021 ( USD Million )
  3. Asia Pacific Viral Infection Controlling Methods Market By Region, From 2016-2021 ( USD Million )
  4. Asia Pacific Antiviral Chemotherapy Market By Region, From 2016-2021 ( USD Million )
  5. Asia Pacific Interferons Market By Region, From 2016-2021 ( USD Million )
  6. Asia Pacific Virology Market By Application, From 2016-2021 ( USD Million )
  7. Asia Pacific Respiratory Tract Infections Market By Region, From 2016-2021 ( USD Million )
  8. Asia Pacific GI Tract Infections Market By Region, From 2016-2021 ( USD Million )
  9. Asia Pacific Urinary Tract Infections Market By Region, From 2016-2021 ( USD Million )
  10. Asia Pacific Eye Infections Market By Region, From 2016-2021 ( USD Million )
  11. Asia Pacific CNS Infections Market By Region, From 2016-2021 ( USD Million )
  12. Asia Pacific Sexually Transmitted Diseases Market By Region, From 2016-2021 ( USD Million )
  13. Asia Pacific Perinatal Infections Market By Region, From 2016-2021 ( USD Million )
  14. Asia Pacific Virology Market By End User, From 2016-2021 ( USD Million )
  15. Asia Pacific Hospitals Market By Region, From 2016-2021 ( USD Million )
  16. Asia Pacific Clinics Market By Region, From 2016-2021 ( USD Million )
  17. Asia Pacific Laboratories Market By Region, From 2016-2021 ( USD Million )
  18. Asia Pacific Diagnostic Centres Market By Region, From 2016-2021 ( USD Million )
  19. Asia Pacific Blood Banks Market By Region, From 2016-2021 ( USD Million )
  20. Asia Pacific Pharmacies Market By Region, From 2016-2021 ( USD Million )
  21. Japan Virology Market By Type, From 2016-2021 ( USD Million )
  22. Japan Virology Market By Application, From 2016-2021 ( USD Million )
  23. Japan Virology Market By End User, From 2016-2021 ( USD Million )
  24. China Virology Market By Type, From 2016-2021 ( USD Million )
  25. China Virology Market By Application, From 2016-2021 ( USD Million )
  26. China Virology Market By End User, From 2016-2021 ( USD Million )
  27. India Virology Market By Type, From 2016-2021 ( USD Million )
  28. India Virology Market By Application, From 2016-2021 ( USD Million )
  29. India Virology Market By End User, From 2016-2021 ( USD Million )
  30. Australia Virology Market By Type, From 2016-2021 ( USD Million )
  31. Australia Virology Market By Application, From 2016-2021 ( USD Million )
  32. Australia Virology Market By End User, From 2016-2021 ( USD Million )
  33. South Korea Virology Market By Type, From 2016-2021 ( USD Million )
  34. South Korea Virology Market By Application, From 2016-2021 ( USD Million )
  35. South Korea Virology Market By End User, From 2016-2021 ( USD Million )
Middle East And Africa Virology Market By Type (Diagnosing Test, Viral Infection Controlling Methods, Antiviral Chemotherapy, Interferons) By Application (Skin And Soft Tissue Infections, GI Tract Infections, Urinar...
Latin America Virology Market By Type (Diagnosing Test, Viral Infection Controlling Methods, Antiviral Chemotherapy, Interferons) By Application (Skin And Soft Tissue Infections, GI Tract Infections, Urinary Tract I...
Asia Pacific Virology Market By Type (Diagnosing Test, Viral Infection Controlling Methods, Antiviral Chemotherapy, Interferons) By Application (Skin And Soft Tissue Infections, GI Tract Infections, Urinary Tract In...
Europe Virology Market By Type (Diagnosing Test, Viral Infection Controlling Methods, Antiviral Chemotherapy, Interferons) By Application (Skin And Soft Tissue Infections, GI Tract Infections, Urinary Tract Infectio...
North America Virology Market By Type (Diagnosing Test, Viral Infection Controlling Methods, Antiviral Chemotherapy, Interferons) By Application (Skin And Soft Tissue Infections, GI Tract Infections, Urinary Tract I...
Virology Market By Type (Diagnosing Test, Viral Infection Controlling Methods, Antiviral Chemotherapy, Interferons) By Application (Skin And Soft Tissue Infections, GI Tract Infections, Urinary Tract Infection, Eye ...
Middle East And Africa Lateral Flow Assay Market By Product (Reader, Kit), Application (Clinical (Pregnancy, Infectious Disease, Lipid, Cardiac Marker), Veterinary, Drug Development, Food Safety), Technique (Competi...
Latin America Lateral Flow Assay Market By Product (Reader, Kit), Application (Clinical (Pregnancy, Infectious Disease, Lipid, Cardiac Marker), Veterinary, Drug Development, Food Safety), Technique (Competitive, Mul...
Asia Pacific Lateral Flow Assay Market By Product (Reader, Kit), Application (Clinical (Pregnancy, Infectious Disease, Lipid, Cardiac Marker), Veterinary, Drug Development, Food Safety), Technique (Competitive, Mult...
Europe Lateral Flow Assay Market By Product (Reader, Kit), Application (Clinical (Pregnancy, Infectious Disease, Lipid, Cardiac Marker), Veterinary, Drug Development, Food Safety), Technique (Competitive, Multiplex,...
North America Lateral Flow Assay Market By Product (Reader, Kit), Application (Clinical (Pregnancy, Infectious Disease, Lipid, Cardiac Marker), Veterinary, Drug Development, Food Safety), Technique (Competitive, Mul...
Lateral Flow Assay Market By Product (Reader, Kit), Application (Clinical (Pregnancy, Infectious Disease, Lipid, Cardiac Marker), Veterinary, Drug Development, Food Safety), Technique (Competitive, Multiplex, Sandwi...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.